Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2026-04-17 19:26:28 ET · period of report 2026-04-15 · accession 0001610717-26-000146 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-04-17 19:26 | 2026-04-15 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $4.61 | +120.0K | 396.7K | +43% | +$552.7K |
| DT | 2026-04-17 19:26 | 2026-04-15 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $150.09 | -120.0K | 276.7K | -30% | -$18.01M |
| DMT | 2026-04-17 19:26 | 2026-04-15 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.00 | -120.0K | 424.1K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-15 | M | A | 23,244 | $4.09 | 299,942 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024. (F2) Includes 201,150 restricted stock units. |
| 2 | Common | Common Stock | 2026-04-15 | M | A | 96,756 | $4.73 | 396,698 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024. (F2) Includes 201,150 restricted stock units. |
| 3 | Common | Common Stock | 2026-04-15 | S | D | 120,000 | $150.09 | 276,698 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024. (F3) This transaction was executed in multiple trades at prices ranging from $150.00 to $150.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes 201,150 restricted stock units. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-04-15 | M | D | 23,244 | $0.00 | 24,464 | D | $4.09 · 2023-03-13 to 2029-03-12 | 23,244 Common Stock | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-04-15 | M | D | 96,756 | $0.00 | 424,085 | D | $4.73 · 2023-08-09 to 2029-08-08 | 96,756 Common Stock | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024. |